Form4insider filings, from the source

SEC Form 4 · accession 0001645627-17-000080

ENDONOVO THERAPEUTICS, INC. · ENDV

Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗

Reporting owner
Michael Scott Mann
Officer — President · 10% Owner
Period of report
Jun 12, 2017
Accepted (ET)
Jun 15, 2017 · 3:01 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001528172

Table I — non-derivative securities

SecurityDateCodeSharesPriceA/DOwned afterD/INature of ownership
Common StockJun 12, 2017P1,000$0.057A21,180,349D
Common StockJun 12, 2017P1,000$0.056A21,181,349D
Common StockJun 12, 2017P1,000$0.056A21,182,349D
Common StockJun 12, 2017P1,000$0.056A21,183,349D
Common StockJun 12, 2017P1,000$0.056A21,184,349D
Common StockJun 12, 2017P1,000$0.056A21,185,349D
Common StockJun 12, 2017P10,000$0.056A21,195,349D
Common StockJun 12, 2017P1,000$0.056A21,196,349D
Common StockJun 12, 2017P1,000$0.0558A21,197,349D
Common StockJun 13, 2017P1,000$0.06A21,198,349D
Common StockJun 13, 2017P1,000$0.06A21,199,349D
Common StockJun 13, 2017P1,000$0.0559A21,200,349D
Common StockJun 13, 2017P1,000$0.057A21,201,349D
Common StockJun 13, 2017P1,000$0.058A21,202,349D
Common StockJun 13, 2017P1,000$0.0579A21,203,349D
Common StockJun 14, 2017P1,000$0.059A21,204,349D
Common StockJun 14, 2017P1,000$0.059A21,205,349D
Common StockJun 14, 2017P1,000$0.056A21,206,349D
Common StockJun 14, 2017P1,000$0.056A21,207,349D
Common StockJun 14, 2017P1,000$0.0543A21,208,349D
Common StockJun 14, 2017P1,000$0.0543A21,209,349D
Common StockJun 14, 2017P1,000$0.0538A21,210,349D
Common StockJun 14, 2017P1,000$0.054A21,211,349D
Common StockJun 14, 2017P1,000$0.054A21,212,349D
Common StockJun 14, 2017P1,000$0.054A21,213,349D
Common StockJun 14, 2017P1,000$0.054A21,214,349D
Common StockJun 14, 2017P1,000$0.054A21,215,349D
Common StockJun 14, 2017P1,000$0.054A21,216,349D
Common StockJun 14, 2017P1,000$0.0543A21,217,349D

Table II — derivative securities

No Table II lines on this filing.